Mirum Pharmaceuticals (MIRM) has an average rating of Buy and mean price target of $146.36, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $103.03, Change: $-7.05, Percent Change: -6.40%
Fastly (FSLY) reported Q1 adjusted earnings late Wednesday of $0.13 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.08.Revenue in the three months ended March 31 rose to $173 million from $144.5 million a year earlier.Analysts surveyed by FactSet expected $171.8 million.Fastly expects Q2 non-GAAP net income of $0.05 to $0.08 a share on revenue of $170 million to $176 million. Analysts polled by FactSet project EPS of $0.04 on revenue of $169.8 million.The company expects full-year non-GAAP net income of $0.27 to $0.33 a share on revenue of $710 million to $725 million. Analysts project EPS of $0.27 on revenue of $712 million.Fastly shares tumbled 28% in after-hours trading.
Tutor Perini (TPC) reported Q1 adjusted earnings late Wednesday of $1.03 per diluted share, up from $0.65 a year earlier.Four analysts polled by FactSet expected $0.95.Revenue in the three months ended March 31 rose to $1.39 billion from $1.25 billion a year earlier.Four analysts surveyed by FactSet expected $1.44 billion.The company affirmed its full-year adjusted EPS guidance of $4.90 to $5.30. Analysts expect $5.Tutor Perini shares fell 6.6% in after-hours trading.
Murphy Oil (MUR) reported Q1 adjusted earnings late Wednesday of $0.32 per diluted share, down from $0.56 a year earlier.Analysts polled by FactSet expected $0.32.Revenue in the three months ended March 31 rose to $733.6 million from $665.2 million a year earlier.Analysts surveyed by FactSet expected $703 million.Murphy shares fell 2.3% in after-hours trading.